• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Catalog Number 7510600
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ossification (1428); Muscle Spasm(s) (1966); Pain (1994); Seroma (2069); Swelling (2091); Weakness (2145); Injury (2348)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Although it is unknown if the device contributed to the reported event, we are filing this mdr for notification purposes.
 
Event Description
It was reported that on: on (b)(6) 2011: the patient presented with following pre-operative diagnoses: failure of previous lumbar fusion, t3-l4 with subsequent l4 vertebral body and pedicle fracture.Post fracture kyphosis and loss of sagittal balance and progressive post fracture scoliosis l3-4 status post deformity and postsurgically related fracture l4.Postsurgical kyphosis and degenerative disk disease with associated possible intermittent spinal cord compression due to mobile kyphosis t2-t3.Patient being status post revision instrumentation with removal of previously placed hardware t3-l4 with re-instrumentation c7 to the pelvis performed on (b)(6) 2011.The patient underwent the following procedures: completion of pedicle subtraction osteotomy l4.Transverse lumbar interbody fusion for stabilization of progressive generative disk disease, l3-4.Completion of instrumentation and fusion c7 to the pelvis with local bone grafting.Per op notes, bone grafting was performed after decortication of the cervical and thoracic spine from c7 down to approximately t6, posterior allografting was then performed using a combination of local bone, beta tricalcium phosphate and bone morphogenic protein placed directly over the exposed decorticated surfaces bridging the area.Similar grafting procedure was then done of the lumbar spine from approximately from the fusion mass of the lumbosacral junction up into the upper lumbar spine at approximately t12-l1.With posterior grafting completed bilaterally at each junctional segment, the surgical wound was then irrigated and then closed.There were no known patient complications.Postop patient continues to suffer from daily severe and disabling pain in her back, weakness in her upper extremities, abnormal bone growth, a large swelling at the cervicothoracic spine, and the appearance of solid nodules of unknown etiology in her lungs.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key6092042
MDR Text Key59555080
Report Number1030489-2016-03124
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Attorney
Type of Report Initial,Followup,Followup
Report Date 02/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/10/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2013
Device Catalogue Number7510600
Device Lot NumberM110909AAG
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/09/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/01/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age56 YR
Patient Weight104
-
-